Claudio Tomi-Andrino
Metabolic modeling-based drug repurposing in Glioblastoma
Tomi-Andrino, Claudio; Pandele, Alina; Winzer, Klaus; King, John; Rahman, Ruman; Kim, Dong-Hyun
Authors
Alina Pandele
KLAUS WINZER klaus.winzer@nottingham.ac.uk
Associate Professor
JOHN KING JOHN.KING@NOTTINGHAM.AC.UK
Professor of Theoretical Mechanics
RUMAN RAHMAN RUMAN.RAHMAN@NOTTINGHAM.AC.UK
Professor of Molecular Neuro-Oncology
DONG-HYUN KIM Dong-hyun.Kim@nottingham.ac.uk
Associate Professor
Abstract
The manifestation of intra- and inter-tumor heterogeneity hinders the development of ubiquitous cancer treatments, thus requiring a tailored therapy for each cancer type. Specifically, the reprogramming of cellular metabolism has been identified as a source of potential drug targets. Drug discovery is a long and resource-demanding process aiming at identifying and testing compounds early in the drug development pipeline. While drug repurposing efforts (i.e., inspecting readily available approved drugs) can be supported by a mechanistic rationale, strategies to further reduce and prioritize the list of potential candidates are still needed to facilitate feasible studies. Although a variety of ‘omics’ data are widely gathered, a standard integration method with modeling approaches is lacking. For instance, flux balance analysis is a metabolic modeling technique that mainly relies on the stoichiometry of the metabolic network. However, exploring the network’s topology typically neglects biologically relevant information. Here we introduce Transcriptomics-Informed Stoichiometric Modelling And Network analysis (TISMAN) in a recombinant innovation manner, allowing identification and validation of genes as targets for drug repurposing using glioblastoma as an exemplar.
Citation
Tomi-Andrino, C., Pandele, A., Winzer, K., King, J., Rahman, R., & Kim, D.-H. (2022). Metabolic modeling-based drug repurposing in Glioblastoma. Scientific Reports, 12, Article 11189. https://doi.org/10.1038/s41598-022-14721-w
Journal Article Type | Article |
---|---|
Acceptance Date | Jun 10, 2022 |
Online Publication Date | Jul 1, 2022 |
Publication Date | Jul 1, 2022 |
Deposit Date | Jun 28, 2022 |
Publicly Available Date | Jul 4, 2022 |
Journal | Scientific Reports |
Electronic ISSN | 2045-2322 |
Publisher | Nature Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 12 |
Article Number | 11189 |
DOI | https://doi.org/10.1038/s41598-022-14721-w |
Keywords | Multidisciplinary |
Public URL | https://nottingham-repository.worktribe.com/output/8764835 |
Publisher URL | https://www.nature.com/articles/s41598-022-14721-w |
Files
Metabolic modeling-based drug repurposing in Glioblastoma
(2.6 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Multicellular mathematical modelling of mesendoderm formation in amphibians
(2016)
Journal Article
The Hele-Shaw injection problem for an extremely shear-thinning fluid
(2015)
Journal Article
Vertex-element models for anisotropic growth of elongated plant organs
(2013)
Journal Article
Systems Analysis of Auxin Transport in the Arabidopsis Root Apex
(2014)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search